Research and Markets: Blood Banking And Blood Products - Global Strategic Business Report

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/nwlf7m/blood_banking_and) has announced the addition of the "Blood Banking And Blood Products - Global Strategic Business Report" report to their offering.

“Blood Banking And Blood Products - Global Strategic Business Report”

This report analyzes the worldwide markets for Blood Banking and Blood Products in US$ Million by the following Product Segments: Blood Components and Plasma Products (Whole Blood & Cellular Components, & Plasma Fractions), and Equipment, Blood Tests and Other Consumables (Includes blood screening and related QC function, but excludes patient diagnosis). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets.

The report profiles 232 companies including leading blood banks such as AABB, Americas Blood Centers, American Red Cross, Canadian Blood Services, Japan Red Cross, National Blood Foundation, and New York Blood Center. Some of the leading players in Blood Bank Technology & Supplies also discussed in this report include Beckman Coulter Inc., Becton Dickinson and Company, BioMerieux SA, CSL Behring LLC, Daxor Corporation, Fenwal Inc., Gen-Probe, Inc., Haemonetics Corp, Hemagen Diagnostics Inc., Immucor Inc., Kawasumi Laboratories, Inc., Novartis Vaccines and Diagnostics, Inc., Terumo Corporation, Terumo BCT Inc., ThermoGenesis Corp., and Velico Medical, Inc. Leading Players discussed under the Plasma Fractionation segment include Baxter International Inc., Beijing Tiantan Biological Products Co., Ltd., Bharat Serums, Bio Products Laboratory, Biotest AG, CSL Limited, Grifols, S.A, Guizhou Taibang Biological Products Co., Ltd., Huanlan Biological Engineering Inc., Kedrion S.p.A., Laboratoire Français du Fractionnement et des Biotechnologies, Octapharma AG, OMRIX Biopharmaceuticals Ltd., Shanghai RAAS Blood Products Co., Ltd., Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd., and Sanquin. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

2. MARKET TRENDS & ISSUES

3. PRODUCT OVERVIEW

4. BLOOD COLLECTION METHODS

5. THE CHANGING LANDSCAPE OF TRANSFUSION TECHNOLOGIES & TESTS

6. BLOOD TRANSFUSION: THE PROCESS, TESTS/TECHNOLOGIES

7. ALTERNATIVES TO BLOOD TRANSFUSION: A REAL THREAT TO THE INDUSTRY

8. BLOOD SUBSTITUTES

9. PRODUCT INNOVATIONS/LAUNCHES IN RECENT PAST - A PERSPECTIVE BUILDER